| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 94b13781-6a90-41b8-b82a-29e93cf1aa9d | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | AMOXICILLIN | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | INDOMETHACIN | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | ERYTHROCIN® STEARATE (erythromycin stearate tablets, USP) Filmtab® Tablets | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 41361b56-1d2d-4368-9bef-42686e14e477 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use phentermine hydrochloride capsules, USP safely and effectively. See full prescribing information for phentermine hydrochloride capsules, USP. PHENTERMINE Hydrochloride Capsules, USP CIV Initial U.S. Approval: 1959 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Unknown Title | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use ZOHYDRO ® ER safely and effectively. See full prescribing information for ZOHYDRO ® ER. ZOHYDRO ® ER (hydrocodone bitartrate) extended‑release capsules, for oral use, CII Initial U.S. Approval: 1943 | 20 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use calcium acetate capsules safely and effectively. See full prescribing information for calcium acetate capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 1990 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use ZOHYDRO ® ER safely and effectively. See full prescribing information for ZOHYDRO ® ER. ZOHYDRO ® ER (hydrocodone bitartrate) extended‑release capsules, for oral use, CII Initial U.S. Approval: 1943 | 13 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Extended Phenytoin Sodium Capsules USP, 100 mg | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PROMETHAZINE WITH CODEINE SYRUP (PROMETHAZINE HYDROCHLORIDE, USP AND CODEINE PHOSPHATE, USP) | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 | 1 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Donnatal Elixir 4oz grape flavor | 7 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DONNATAL ELIXIR grape flavor 1 pint | 7 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Donnatal Elixir Mint 16 oz | 4 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Donnatal Elixir Mint 4 oz | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use amoxicillin for oral suspension safely and effectively. See full prescribing information for amoxicillin for oral suspension, USP. Amoxicillin for Oral Suspension, USP Initial U.S. Approval: 1974 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 8ce8124a-73e0-44cc-a804-9a470ba60e41 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 2001 | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | GABAPENTIN CAPSULES, USP Rx Only Rev. 09/2011 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 347eb1a3-1957-4a4b-a0d5-1576adae3d13 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Indomethacin Capsules, USP 04/2011 Rx Only | 1 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Infant's Gas Relief Original Formula | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PROMETHAZINE WITH CODEINE SYRUP (PROMETHAZINE HYDROCHLORIDE, USP AND CODEINE PHOSPHATE, USP) | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Drug Facts | 4 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | phocal™ | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP safely and effectively. See full prescribing information for dicyclomine hydrochloride capsules, USP and dicyclomine hydrochloride tablets, USP. Dicyclomine hydrochloride capsules USP, for oral use Dicyclomine hydrochloride tablets USP, for oral use Initial U.S. Approval: 1950 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Unknown Title | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 303c1dba-7c14-4fc9-9e87-a9b705168491 | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use ziprasidone hydrochloride safely and effectively. See full prescribing information for ziprasidone hydrochloride. Ziprasidone Hydrochloride Capsules Initial U.S. Approval: 2001 | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use ziprasidone hydrochloride safely and effectively. See full prescribing information for ziprasidone hydrochloride. Ziprasidone Hydrochloride Capsules Initial U.S. Approval: 2001 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Indomethacin Capsules, USP Rx Only | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Infants Simethicone Drops | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HCI 15MG USP CAPSULES PHENTERMINE HCI 30MG USP CAPSULES Rx Only | 1 | |
| FD&C Red NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Extended Phenytoin Sodium Capsules USP, 100 mg | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use Vyvanse safely and effectively. See full prescribing information for Vyvanse. Vyvanse ® (lisdexamfetamine dimesylate) Capsules, CII Initial U.S. Approval: 2007 | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Amoxicillin for Oral Suspension, USP | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Flurazepam Hydrochloride Capsules, USP | 2 | |
| FD&C Red NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP CIII Rx only | 1 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules CIII | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | GABAPENTIN CAPSULES USP 1039 Rx only | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | dfd184f0-2e52-454c-8ef2-3153be7dd4c9 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Appformin | 9 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Appformin-D | 6 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Appbutamone | 5 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Theracodophen-Low-90 | 13 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Theraproxen | 7 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Therabenzaprine-60 | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Therapentin-60 | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Theraprofen-60 | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Theratramadol-60 | 3 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Amoxicillin Capsules, USP 250 mg and 500 mg | 5 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | a6b1858a-e796-4cb0-8a4d-d5c521874e84 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 1990 | 7 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | e3e27c8f-64d5-4e6e-bb2d-5dd3a2e3daa1 | 2 | |
| Fd&c Red No. 3 | ACTIVE INGREDIENT | PN2ZH5LOQY | Allergies | 1 | |
| Fd&c Red No. 3 | ACTIVE INGREDIENT | PN2ZH5LOQY | Allergies | 1 | |
| Fd&c Red No. 3 | ACTIVE INGREDIENT | PN2ZH5LOQY | Food Allergy - Additive | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | AMOXICILLIN powder, for suspension | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS, USP CIII Rx only | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HCI 15MG USP CAPSULES PHENTERMINE HCI 30MG USP CAPSULES Rx Only | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HCI 15MG USP CAPSULES PHENTERMINE HCI 30MG USP CAPSULES Rx Only | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Extended Phenytoin Sodium Capsules USP, 100 mg | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Nitroglycerin Slocaps Nitroglycerin Sustained-release Capsules 2.5 mg, 6.5 mg, 9 mg | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Flurazepam Hydrochloride Capsules, USP | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Dicyclomine Hydrochloride Tablets, USP Dicyclomine Hydrochloride Capsules, USP Rx Only | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PROMETHAZINE WITH CODEINE SYRUP (PROMETHAZINE HYDROCHLORIDE, USP AND CODEINE PHOSPHATE, USP) | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HYDROCHLORIDE CAPSULES, USP CIV | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use Atomoxetine Hydrochloride Capsules safely and effectively. See full prescribing information for Atomoxetine Hydrochloride Capsules Initial U.S. Approval: 2002 | 4 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Amoxicillin for Oral Suspension, USP | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 787cda7d-7aa4-4909-8e5c-f2fcf68828e4 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 6c826b0a-ac87-48cc-a780-9a4a2118e8a8 | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | 4b5513c3-b57f-46f1-9855-dad1063aa4c9 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Calcium Acetate Capsules | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Dilantin ® (Extended Phenytoin Sodium Capsules, USP) | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Norpace disopyramide phosphate capsules Norpace CR disopyramide phosphate extended-release capsules ® ® | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | SIMETHICONE, CAPSULES USP 125MG | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | e5c28db5-efce-49a7-9e5f-12338d1f216b | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | These highlights do not include all the information needed to use fluoxetine safely and effectively. See full prescribing information for fluoxetine capsules. Initial U.S. Approval: 1987 | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | Amoxicillin | 2 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PROMETHAZINE WITH CODEINE SYRUP (PROMETHAZINE HYDROCHLORIDE, USP AND CODEINE PHOSPHATE, USP) | 1 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | VYVANSE (LISDEXAMFETAMINE DIMESYLATE) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3842 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PROMETHAZINE WITH CODEINE (PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE) SYRUP [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3688 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3413 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | E.E.S. (ERYTHROMYCIN ETHYLSUCCINATE) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 1405 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CEFACLOR CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CLOMIPRAMINE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CEFACLOR CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | ERYTHROCIN STEARATE (ERYTHROMYCIN STEARATE) TABLET, FILM COATED [BRYANT RANCH PREPACK] | 1000 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | FLURAZEPAM (FLURAZEPAM HYDROCHLORIDE) CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DILANTIN (PHENYTOIN SODIUM ) CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ] | 112 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CALCIUM ACETATE (CALCIUM ACETATE) CAPSULE [REMEDYREPACK INC. ] | 79 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | VYVANSE (LISDEXAMFETAMINE DIMESYLATE) CAPSULE [SHIRE LLC] | 54 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | SEROMYCIN (CYCLOSERINE) CAPSULE [REMEDYREPACK INC. ] | 52 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 28 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CARBATROL (CARBAMAZEPINE) CAPSULE, EXTENDED RELEASE [SHIRE US MANUFACTURING INC.] | 26 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DILANTIN (PHENYTOIN SODIUM) CAPSULE, EXTENDED RELEASE [PARKE-DAVIS DIV OF PFIZER INC] | 24 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DIBENZYLINE (PHENOXYBENZAMINE HYDROCHLORIDE) CAPSULE [WELLSPRING PHARMACEUTICAL CORPORATION] | 21 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HYDROCHLORIDE CAPSULE [EON LABS, INC.] | 17 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | FELDENE (PIROXICAM) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 16 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | PHENTERMINE HYDROCHLORIDE CAPSULE [LANNETT COMPANY, INC.] | 16 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CALCIUM ACETATE CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 15 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE CAPSULE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE CAPSULE AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BENAZEPRIL HYDROCHLORIDE) CAPSULE [MYLAN PHARMACEUTICALS INC.] | 14 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | ZARONTIN (ETHOSUXIMIDE) CAPSULE [PARKE-DAVIS DIV OF PFIZER INC] | 14 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DICYCLOMINE HYDROCHLORIDE TABLET DICYCLOMINE HYDROCHLORIDE CAPSULE [LANNETT COMPANY, INC.] | 13 | |
| FD&C Red No. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | QSYMIA (PHENTERMINE AND TOPIRAMATE) CAPSULE, EXTENDED RELEASE [VIVUS, INC.] | 13 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE WITH CODEINE PHOSPHATE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE) CAPSULE [WEST-WARD PHARMACEUTICALS CORP] | 12 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [ATLANTIC BIOLOGICALS CORPS] | 12 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | EMBEDA (MORPHINE SULFATE AND NALTREXONE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [PFIZER LABORATORIES DIV PFIZER INC] | 12 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | NITROFURANTOIN MONOHYDRATE MACROCRYSTALS CAPSULE [ACTAVIS PHARMA, INC.] | 12 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | OLANZAPINE AND FLUOXETINE CAPSULE [SANDOZ INC] | 12 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | CEFACLOR CAPSULE [WEST-WARD PHARMACEUTICALS CORP] | 11 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | COLCHICINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 11 | |
